OPTIRAY 350 Drug Patent Profile
✉ Email this page to a colleague
When do Optiray 350 patents expire, and what generic alternatives are available?
Optiray 350 is a drug marketed by Liebel-flarsheim and is included in two NDAs.
The generic ingredient in OPTIRAY 350 is ioversol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ioversol profile page.
Summary for OPTIRAY 350
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 3 |
Patent Applications: | 2,047 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPTIRAY 350 at DailyMed |
Recent Clinical Trials for OPTIRAY 350
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GE Healthcare | Phase 4 |
Bayer | Phase 4 |
Guerbet/Liebel-Flarsheim | Phase 4 |
Pharmacology for OPTIRAY 350
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for OPTIRAY 350
US Patents and Regulatory Information for OPTIRAY 350
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 350 | ioversol | INJECTABLE;INJECTION | 019710-005 | Jan 22, 1992 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Liebel-flarsheim | OPTIRAY 350 | ioversol | INJECTABLE;INJECTION | 020923-003 | May 28, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OPTIRAY 350
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 350 | ioversol | INJECTABLE;INJECTION | 019710-005 | Jan 22, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Liebel-flarsheim | OPTIRAY 350 | ioversol | INJECTABLE;INJECTION | 020923-003 | May 28, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OPTIRAY 350
See the table below for patents covering OPTIRAY 350 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 552188 | ⤷ Try a Trial | |
European Patent Office | 0083964 | COMPOUNDS SUITABLE FOR X-RAY VISUALISATION METHODS | ⤷ Try a Trial |
Japan | S58131970 | COMPOUND | ⤷ Try a Trial |
Australia | 9151182 | ⤷ Try a Trial | |
Japan | H0224252 | ⤷ Try a Trial | |
Germany | 3362967 | ⤷ Try a Trial | |
Netherlands | 930067 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OPTIRAY 350
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0083964 | SPC/GB93/089 | United Kingdom | ⤷ Try a Trial | SPC/GB93/089: 20041015 |
0083964 | 93C0142 | Belgium | ⤷ Try a Trial | PRODUCT NAME: IOVERSOL; NAT. REGISTRATION NO/DATE: 74 IS 56 F12/19910521; FIRST REGISTRATION: NL RVG 13345 19891016 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |